In:
Acute and Critical Care, The Korean Society of Critical Care Medicine, Vol. 38, No. 4 ( 2023-11-30), p. 389-398
Abstract:
Extracorporeal membrane oxygenation (ECMO) is a life-saving intervention for patients with refractory cardiorespiratory failure. Despite its benefits, ECMO carries a significant risk of neurological complications, including acute brain injury (ABI). Although standardized neuromonitoring and neurological care have been shown to improve early detection of ABI, the inability to perform neuroimaging in a timely manner is a major limitation in the accurate diagnosis of neurological complications. Therefore, blood-based biomarkers capable of detecting ongoing brain injury at the bedside are of great clinical significance. This review aims to provide a concise review of the current literature on plasma biomarkers for ABI in patients on ECMO support.
Type of Medium:
Online Resource
ISSN:
2586-6052
,
2586-6060
DOI:
10.4266/acc.2023.01368
Language:
English
Publisher:
The Korean Society of Critical Care Medicine
Publication Date:
2023
detail.hit.zdb_id:
3003021-3
